INSUBCONTINENT EXCLUSIVE:
Hyderabad: Bharat Biotech has actually chosen to increase its vaccine production capability for Covaxin by including yet another assembly
line at its Ankleshwar-based subsidiary, Chiron Behring Vaccines
The company has actually currently been producing its Covid-19 vaccine at its Hyderabad and Bengaluru facilities.The business said it plans
to produce 20 crore doses of Covaxin per year in the GMP centers that are already operational for the production of vaccines
The product availability at Ankleshwar, the company said, will commence from October 2021
The additional manufacturing at Chiron Behring would efficiently take the volumes approximately 100 crore doses per annum, with its own
